Items where authors include "Wells-Jordan, P."

Article

Fennell, D.A. orcid.org/0000-0001-7373-1312, Hill, K. orcid.org/0000-0001-5289-4454, Zhang, M. et al. (37 more authors) (2025) Constitutive inflammation and epithelial-mesenchymal transition dictate sensitivity to nivolumab in CONFIRM: a placebo-controlled, randomised phase III trial. Nature Communications, 16 (1). 6688. ISSN 2041-1723

Fennell, D.A., Ewings, S., Ottensmeier, C. et al. (36 more authors) (2021) Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial. The Lancet Oncology, 22 (11). pp. 1530-1540. ISSN 1470-2045